
Pharmaceuticals • Biotechnology
Cristcot is a strategic pharmaceutical company focused on gastroenterology, developing a novel hydrocortisone acetate (HCA) suppository formulation and delivery device intended as a rapid-acting rescue therapy for ulcerative colitis (UC). Its lead product has completed Phase 3 clinical trials with an endpoint of mucosal healing and clinical remission in four weeks, and is designed for use alone or alongside maintenance therapies. Cristcot holds composition, utility, device and manufacturing patents and aims to address an unmet need in UC treatment by improving drug placement, reducing leakage, increasing retention and accelerating bioavailability.
11 - 50 employees
Founded 2008
💊 Pharmaceuticals
🧬 Biotechnology
November 22
Associate Director of Market Access Analytics at Cristcot focusing on data analytics and market research. Collaborating with cross-functional teams for informed market access strategy decisions.
November 21
Associate Director of Data Science guiding data-driven strategic business decisions for Cristcot's ulcerative colitis treatment launch. Collaborating cross-functionally to turn analytics into actionable insights for brand performance.
November 21
Associate Director of Field Force Analytics leveraging data analytics to inform Cristcot's business decisions. Collaborating across teams to deliver actionable insights for field performance.
November 21
Associate Director of Forecasting responsible for developing and utilizing forecasting capabilities at Cristcot. Collaborating across teams to communicate commercial opportunities for launch assets.
November 21
Director of Medical Affairs Strategy and Scientific Engagement at Cristcot, overseeing Integrated Medical Affairs Plan execution and cross-functional collaboration.
November 21
Director of Medical Information leading medical information activities and materials for Cristcot’s portfolio. Collaborating with various departments and ensuring compliance with regulations in a remote role.
November 21
Director of Patient and Professional Advocacy building relationships with patient organizations, ensuring patient perspectives influence strategies and initiatives. Focus on ulcerative colitis within the biotechnology and pharmaceutical healthcare industries.
November 21
Senior Director responsible for field medical activities and team management in the US. Supporting Cristcot's ulcerative colitis therapy launch and ensuring alignment with brand strategies.
November 21
Strategic leader for developing and executing HEOR strategies and evidence generation plans at Cristcot. Collaborating with cross-functional teams and external partners to ensure product value and reimbursement.
November 21
Senior Director, Publications leading development and execution of publication plans for Cristcot’s portfolio. Collaborating with cross-functional teams and external stakeholders to drive scientific communications.